Choose a language and wait for the translated text.
The drugmaker said it will be the first life sciences company to buy an Nvidia DGX SuperPOD based on its Vera Rubin systems. The chipmaker unveiled its Vera Rubin architecture earlier this year as the successor to its current generation of AI computing systems.
Bristol Myers buys Nvidia's latest AI computing system for drug research | PharmaVoice
